Tue 31'st Jul 2018
Atara Biotherapeutics Stock Analysis
Technical stock analysis for Tue 31'st Jul 2018
|Shorts||10.21% ( 2018-07-13 )|
Atara Biotherapeutics gained 4.74% in the last trading day, rising from $35.85 to $37.55 The price has fallen in 7 of the last 10 days and is down by -7.28% for this period. Volume fell in the last day by -361 145 shares, and in total, 414 908 shares bought and sold for approximately $15.58 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Atara Biotherapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.05% during the next 3 months and, with 90% probability hold a price between $26.47 and $37.53 at the end of this period.
A buy signal was issued from a pivot bottom point on Monday July 30, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Atara Biotherapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $38.11 and $40.58. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 40 and the stock is currently not being overbought or oversold
Support & Resistance
Atara Biotherapeutics finds support from accumulated volume at $36.75.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.90 (5.32%) between high and low. For the last week, the stock has had a daily average volatility of 5.48%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Atara Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.Click for Top 5 Sell Candidates